AquAdvantage salmon

Last updated
Wild-type Atlantic salmon (Salmo salar) Salmo salar GLERL 1.jpg
Wild-type Atlantic salmon ( Salmo salar )

AquAdvantage salmon is a genetically engineered (GE) fish, a GE Atlantic salmon developed by AquaBounty Technologies in 1989. The typical growth hormone-regulating gene in the Atlantic salmon was replaced with the growth hormone-regulating gene from Pacific Chinook salmon, with a promoter sequence from ocean pout. This gene enables GM salmon to grow year-round instead of only during spring and summer. [1]

Contents

These GE salmon are a commercially competitive alternative to wild-caught salmon and to fish farming of unmodified salmon. The purpose of the modifications is to increase the speed at which the fish grows without affecting its ultimate size or other qualities. Fish-farmed Atlantic salmon growth rates have already been improved over wild fish as a result of traditional selective breeding practices. However, GM fish are able to grow even faster and grow to market size in just 16 to 18 months rather than three years. [2]

Significance

AquAdvantage salmon were the first genetically engineered animals approved for human consumption in the United States and Canada. [3] [4] This approval has been subject to much controversy. [5]

Genetic modification

The AquAdvantage salmon was developed in 1989 by the addition of a single copy of the opAFP-GHc2 construct, which consists of a promoter sequence from ocean pout directing the production of a growth hormone protein using the coding sequence from Chinook salmon. [6] : vii, 8  The continuous expression of this transgene allows the fish to grow all year-round instead of only during spring and summer. [7] The stability of the new DNA construct was tested, revealing no additional mutational effects during insertion other than the two desired genes. [1] These GM fish were back-crossed (a two-generation breeding protocol that starts by generating a hybrid offspring between two inbred strains, one of them carrying the mutation of interest) to wild-type Atlantic salmon, and the genetically modified EO-1ɑ gene sequence was identical in the second through fourth generations, indicating that the insertion is stable. [1]

While wild Atlantic salmon (Salmo salar) have two sets of chromosomes, raised AquaAdvantage salmon have three sets (i.e. triploid). Induction of triploidy by treatment of eggs renders the fish sterile, reducing the risk of interbreeding with wild-type fish if any of the genetically modified fish were introduced into the wild. [8]

Concerns

There are three main concerns regarding the approval of GE salmon: consumption of these fish could be harmful, there could be unintended consequences of the gene alteration, and non-sterile fish could escape and intermingle with the wild population. Risks assessments have been conducted to determine the health and safety of this technology and a number of preventatives have been implemented to prevent the release of these fish into the wild. [9]

Human health risk assessment

Fish are one of the eight food types that the Food and Drug Administration (FDA) is required, by law, to treat with special care, with regard to allergies. [6] : 97  As part of the regulatory process, the FDA required data on whether changes occur in the kinds or levels of fish allergens (such as parvalbumin) in AquAdvantage. The FDA has upheld that people with allergies to Atlantic Salmon will likely be allergic to AquAdvantage Salmon due to the similar species properties, but not because it is genetically engineered [9] and that AquAdvantage Salmon is as safe to eat as non-GE salmon because there are no significant food safety hazards associated with AquAdvantage. [10] Other human health concerns arise due to the increased hormone content in the edible tissue of transgenic fish. [11] The AquAdvantage salmon showed a statistical difference in the concentration of an insulin-like growth factor, yet the amount of (IGF-1) found in AquAdvantage salmon is similar to, or lower than, other amounts found in other common animal products such as organic cow milk. [8]

Off-target effects of gene editing

A concern with genetic engineering is that another gene other than the one intended may also be accidentally edited. [5] The genome sequence of the AquAdvantage salmon has been analyzed and no off-target effects or changes in other genes have been detected. [8]

Precautionary containment procedures

Critics raised concerns about potential environmental impacts if these fish reached the rivers or oceans. Modeled invasion scenarios in semi-natural environments suggest that GM salmon would out-compete wild-type salmon. [12] [13] To address concerns about biological containment, the FDA requires AquaBounty to take precautionary measures to ensure that transgenic fish do not mix with the wild population. Aquaculture that uses conventionally bred salmon, mostly Atlantic salmon, cultivates the fish in net pens. In North America, this occurs mostly in coastal waters off Washington, British Columbia, and Maine. However, the application for FDA approval of AquAdvantage salmon specified land-based tank cultivation with no ocean involvement. [11] AquaBounty also altered the fish to be only female and sterile. Male fish are created only for egg-producing service and are kept in secure, land-based facilities in Canada. These eggs are then shipped to a land-based aquaculture facility in Indiana.

In order to make the fish sterile AquAdvantage salmon eggs are treated with pressure, to create batches of fish eggs with three copies of each chromosome (triploid) rather than to two copies (diploid). Any batch that contains 5 percent or more diploid fish, is destroyed because these diploid fish are capable of reproducing. [8]

Government regulation

United States

In September 2010, an FDA advisory panel indicated that the fish is "highly unlikely to cause any significant effects on the environment" and that it is "as safe as food from conventional Atlantic salmon". [6] [14] In October 2010, 39 lawmakers asked the FDA to reject the application. Other groups requested that the fish carry a label identifying its transgenic origin. [14] Concerns included alleged flaws in sterilization and isolation, and excessive antibiotic use. [15]

On 25 December 2012, the FDA published a draft environmental assessment for AquAdvantage salmon. [7] The FDA also published a preliminary Finding of No Significant Impact. [16] A 60-day period for the public to comment was to elapse before the FDA reviewed Aquadvantage salmon again, which was arbitrarily extended until May 2013. [17] [5]

The FDA approved AquaBounty Technologies' application to sell the AquAdvantage salmon to U.S. consumers on November 19, 2015. [18] However, a rider to a spending bill signed into law on December 18, 2015 by President Obama bans its import until the FDA mandates labels for the genetically modified product. [19] [20] The decision marks the first time a genetically modified animal has been approved to enter the United States food supply. The decision came nearly twenty years after the company first submitted data to the FDA, and after they had raised ten generations of the animals. [15] The announcement released by the FDA states: "AquAdvantage salmon is as safe to eat as any non-genetically engineered (GE) Atlantic salmon, and also as nutritious." [21] [22] One month later, language was introduced into a proposed federal spending bill requiring consumer notification that the fish is genetically modified. [23] In October, 2018, AquaAdvantage salmon was not being sold in the US and the import of the salmon eggs from Canada to be raised at an AquaAdvantage fish farm in Indiana was prohibited by FDA. [24] However, on March 8, 2019, the import alert issued previously by the FDA was deactivated, and AquAdvantage salmon may now be sold in the U.S. and the salmon eggs may now be imported to the Indiana facility. [25]

On November 5, 2020, the United States District Court for the Northern District of California granted a motion to force the FDA to reconsider its approval of AquAdvantage, holding that the FDA had failed to follow its own procedures by ignoring some environmental consequences of these fish. [26]

Sales in the U.S. started in May 2021. [27]

Canada

On 25 November 2013, Environment Canada approved the product for salmon egg production for commercial purposes in Canada. [28] In May 2016, the Canadian Food Inspection Agency approved the sale of the GM fish. [29] In July 2017, AquaBounty Technologies said they had sold 4.5 tons of AquaAdvantage salmon fillets to customers in Canada.[ citation needed ]

Notes

  1. 1 2 3 Yaskowiak, ES; Shears, MA; Agarwal-Mawal, A; Fletcher, GL (August 2006). "Characterization and multi-generational stability of the growth hormone transgene (EO-1alpha) responsible for enhanced growth rates in Atlantic Salmon". Transgenic Research . Springer. 15 (4): 465–480. doi:10.1007/s11248-006-0020-5. PMID   16906447. S2CID   22247493.
  2. ↑ Blumenthal, Les (August 2, 2010). "Company says FDA is nearing decision on genetically engineered Atlantic salmon". The Washington Post. Retrieved 2 August 2010.
  3. ↑ "FDA Import Alert 99-40 "Genetically Engineered (GE) Salmon"". FDA. 2016-01-29. Archived from the original on 2016-01-31.
  4. ↑ Goldenberg, Suzanne; correspondent, US environment (2013-11-25). "Canada approves production of GM salmon eggs on commercial scale". The Guardian. ISSN   0261-3077 . Retrieved 2019-05-03.
  5. 1 2 3 Reardon, Sarah (28 December 2012). "Approval for gene-modified salmon spawns controversy". New Scientist. Retrieved 2 January 2013.
  6. 1 2 3 FDA 2010.
  7. 1 2 FDA & December 2012.
  8. 1 2 3 4 Bodnar A (October 2010). "Risk Assessment and Mitigation of AquAdvantage Salmon" (PDF). ISB News Report. Archived from the original (PDF) on 2019-04-12. Retrieved 2015-11-24.
  9. 1 2 Bodnar A (October 2010). "Risk Assessment and Mitigation of AquAdvantage Salmon" (PDF). ISB News Report. Archived from the original (PDF) on 2019-04-12. Retrieved 2015-11-24.
  10. ↑ "FDA Has Determined That the AquAdvantage Salmon is as Safe to Eat as Non-GE Salmon". U.S. Food & Drug Administration. 2015-11-19. Archived from the original on 2015-11-19. Retrieved 2018-02-09.
  11. 1 2 von Mogel, Karl Haro (24 April 2013). "Interview with Ron Stotish at BIO". biofortified.org.
  12. ↑ Sundström & Devlin 2010, pp. 447–460.
  13. ↑ Moreau, Conway & Fleming 2011, pp. 736–748.
  14. 1 2 Mundy, Alicia; Tomson, Bill (1 October 2010). "Industry Fights Altered Salmon". The Wall Street Journal. Retrieved 5 November 2016.
  15. 1 2 Naik, Gautam (September 21, 2010). "Gene-Altered Fish Closer to Approval". The Wall Street Journal.
  16. ↑ FDA & May 2012.
  17. ↑ Federal Register 2012.
  18. ↑ "FDA Has Determined That the AquAdvantage Salmon is as Safe to Eat as Non-GE Salmon". U.S. Food & Drug Administration. 2015-11-19. Archived from the original on 2015-11-19. Retrieved 2018-02-09.
  19. ↑ Dennis, Brady (2016-01-29). "FDA bans imports of genetically engineered salmon – for now". Washington Post. Archived from the original on 2016-01-29. Retrieved 2016-04-09.
  20. ↑ "FDA Import Alert 99-40 "Genetically Engineered (GE) Salmon"". FDA. 2016-01-29. Archived from the original on 2016-01-31.
  21. ↑ "FDA Has Determined That the AquAdvantage Salmon is as Safe to Eat as Non-GE Salmon". FDA. 2015-11-19. Archived from the original on 2015-11-19.
  22. ↑ Steenhuysen, Julie; Polansek, Tom (2015-11-19). "U.S. clears genetically modified salmon for human consumption". Reuters. Reuters. Archived from the original on 2015-12-08. Retrieved 2016-04-09.
  23. ↑ Dennis, Brady (17 December 2015). "FDA must develop plan to label genetically engineered salmon, Congress says". The Washington Post. Retrieved 6 April 2016.
  24. ↑ Blank, C (2018-08-08). "AquaBounty sells GMO salmon as losses mount". Seafood Source. Archived from the original on 2018-12-04.
  25. ↑ "Questions and Answers on FDA's Deactivation of an Import Alert for Genetically Engineered Salmon". U.S. Food and Drug Administration. FDA. Retrieved 12 June 2020.
  26. ↑ Nosowitz, Dan (5 November 2020). "Court Nixes FDA's Approval of Genetically Engineered Salmon". Modern Farmer.
  27. ↑ Smith, Casey (21 May 2021). "Genetically modified salmon head to US dinner plates". AP News. Retrieved 6 August 2021.
  28. ↑ Goldenberg, Suzanne; correspondent, US environment (2013-11-25). "Canada approves production of GM salmon eggs on commercial scale". The Guardian. ISSN   0261-3077 . Retrieved 2019-05-03.
  29. ↑ "Canada Approves Sale of Genetically Modified Salmon". Democracy Now. 2016-05-20. Archived from the original on 2016-05-21.

Related Research Articles

<span class="mw-page-title-main">Biotechnology</span> Use of living systems and organisms to develop or make useful products

Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services.

<span class="mw-page-title-main">Genetically modified organism</span> Organisms whose genetic material has been altered using genetic engineering methods

A genetically modified organism (GMO) is any organism whose genetic material has been altered using genetic engineering techniques. The exact definition of a genetically modified organism and what constitutes genetic engineering varies, with the most common being an organism altered in a way that "does not occur naturally by mating and/or natural recombination". A wide variety of organisms have been genetically modified (GM), including animals, plants, and microorganisms.

<span class="mw-page-title-main">Genetic engineering</span> Manipulation of an organisms genome

Genetic engineering, also called genetic modification or genetic manipulation, is the modification and manipulation of an organism's genes using technology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms. New DNA is obtained by either isolating and copying the genetic material of interest using recombinant DNA methods or by artificially synthesising the DNA. A construct is usually created and used to insert this DNA into the host organism. The first recombinant DNA molecule was made by Paul Berg in 1972 by combining DNA from the monkey virus SV40 with the lambda virus. As well as inserting genes, the process can be used to remove, or "knock out", genes. The new DNA can be inserted randomly, or targeted to a specific part of the genome.

<span class="mw-page-title-main">Fish farming</span> Raising fish commercially in enclosures

Fish farming or pisciculture involves commercial breeding of fish, most often for food, in fish tanks or artificial enclosures such as fish ponds. It is a particular type of aquaculture, which is the controlled cultivation and harvesting of aquatic animals such as fish, crustaceans, molluscs and so on, in natural or pseudo-natural environments. A facility that releases juvenile fish into the wild for recreational fishing or to supplement a species' natural numbers is generally referred to as a fish hatchery. Worldwide, the most important fish species produced in fish farming are carp, catfish, salmon and tilapia.

<span class="mw-page-title-main">Genetically modified food</span> Foods produced from organisms that have had changes introduced into their DNA

Genetically modified foods, also known as genetically engineered foods, or bioengineered foods are foods produced from organisms that have had changes introduced into their DNA using various methods of genetic engineering. Genetic engineering techniques allow for the introduction of new traits as well as greater control over traits when compared to previous methods, such as selective breeding and mutation breeding.

<span class="mw-page-title-main">GloFish</span> Brand of genetically modified fluorescent fish

The GloFish is a patented and trademarked brand of fluorescently colored genetically modified aquarium fish. They have been created from several different species of fish: zebrafish were the first GloFish available in pet stores, and recently the skirt tetra, tiger barbs, Rainbow Shark, Siamese fighting fish, and most recently Bronze corydoras have been added to the lineup. They are sold in many colors, trademarked as "Starfire Red", "Moonrise Pink", "Sunburst Orange", "Electric Green", "Cosmic Blue", and "Galactic Purple", although not all species are available in all colors. Although not originally developed for the ornamental fish trade, it is one of the first genetically modified animals to become publicly available. The rights to GloFish are owned by Spectrum Brands, Inc., which purchased GloFish from Yorktown Technologies, the original developer of GloFish, in May 2017.

<span class="mw-page-title-main">Genetically modified crops</span> Plants used in agriculture

Genetically modified crops are plants used in agriculture, the DNA of which has been modified using genetic engineering methods. Plant genomes can be engineered by physical methods or by use of Agrobacterium for the delivery of sequences hosted in T-DNA binary vectors. In most cases, the aim is to introduce a new trait to the plant which does not occur naturally in the species. Examples in food crops include resistance to certain pests, diseases, environmental conditions, reduction of spoilage, resistance to chemical treatments, or improving the nutrient profile of the crop. Examples in non-food crops include production of pharmaceutical agents, biofuels, and other industrially useful goods, as well as for bioremediation.

<span class="mw-page-title-main">Genetic pollution</span> Problematic gene flow into wild populations

Genetic pollution is a term for uncontrolled gene flow into wild populations. It is defined as "the dispersal of contaminated altered genes from genetically engineered organisms to natural organisms, esp. by cross-pollination", but has come to be used in some broader ways. It is related to the population genetics concept of gene flow, and genetic rescue, which is genetic material intentionally introduced to increase the fitness of a population. It is called genetic pollution when it negatively impacts the fitness of a population, such as through outbreeding depression and the introduction of unwanted phenotypes which can lead to extinction.

<span class="mw-page-title-main">Ocean pout</span> Species of fish

The ocean pout is an eelpout in the family Zoarcidae. It is found in the Northwest Atlantic Ocean, off the coast of New England and eastern Canada. The fish has antifreeze proteins in its blood, giving it the ability to survive in near-freezing waters.

<span class="mw-page-title-main">Salmon louse</span> Parasitic crustacean of fish

The salmon louse is a species of copepod in the genus Lepeophtheirus. It is a sea louse, a parasite living mostly on salmon, particularly on Pacific and Atlantic salmon and sea trout, but is also sometimes found on the three-spined stickleback. It feeds on the mucus, skin and blood of the fish. Once detached, they can be blown by wind across the surface of the sea, like plankton. When they encounter a suitable marine fish host, they adhere themselves to the skin, fins, or gills of the fish, and feed on the mucus or skin. Sea lice only affect fish and are not harmful to humans.

<span class="mw-page-title-main">Genetically modified animal</span> Animal that has been genetically modified

Genetically modified animals are animals that have been genetically modified for a variety of purposes including producing drugs, enhancing yields, increasing resistance to disease, etc. The vast majority of genetically modified animals are at the research stage while the number close to entering the market remains small.

<span class="mw-page-title-main">Aquaculture of salmonids</span> Fish farming and harvesting under controlled conditions

The aquaculture of salmonids is the farming and harvesting of salmonid fish under controlled conditions for both commercial and recreational purposes. Salmonids, along with carp and tilapia, are the three most important fish groups in aquaculture. The most commonly commercially farmed salmonid is the Atlantic salmon.

<span class="mw-page-title-main">Genetically modified fish</span>

Genetically modified fish are organisms from the taxonomic clade which includes the classes Agnatha, Chondrichthyes and Osteichthyes whose genetic material (DNA) has been altered using genetic engineering techniques. In most cases, the aim is to introduce a new trait to the fish which does not occur naturally in the species, i.e. transgenesis.

AquaBounty Technologies is a biotechnology company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of salmon has been approved in Canada and the United States.

<span class="mw-page-title-main">History of genetic engineering</span>

Genetic engineering is the science of manipulating genetic material of an organism. The first artificial genetic modification accomplished using biotechnology was transgenesis, the process of transferring genes from one organism to another, first accomplished by Herbert Boyer and Stanley Cohen in 1973. It was the result of a series of advancements in techniques that allowed the direct modification of the genome. Important advances included the discovery of restriction enzymes and DNA ligases, the ability to design plasmids and technologies like polymerase chain reaction and sequencing. Transformation of the DNA into a host organism was accomplished with the invention of biolistics, Agrobacterium-mediated recombination and microinjection. The first genetically modified animal was a mouse created in 1974 by Rudolf Jaenisch. In 1976 the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. In 1983 an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value.

<span class="mw-page-title-main">Fisheries law</span> Regulations regarding fishing activities

Fisheries law is an emerging and specialized area of law. Fisheries law is the study and analysis of different fisheries management approaches such as catch shares e.g. Individual Transferable Quotas; TURFs; and others. The study of fisheries law is important in order to craft policy guidelines that maximize sustainability and legal enforcement. This specific legal area is rarely taught at law schools around the world, which leaves a vacuum of advocacy and research. Fisheries law also takes into account international treaties and industry norms in order to analyze fisheries management regulations. In addition, fisheries law includes access to justice for small-scale fisheries and coastal and aboriginal communities and labor issues such as child labor laws, employment law, and family law.

<span class="mw-page-title-main">Genetically modified tree</span> Tree whose DNA has been modified using genetic engineering techniques

A genetically modified tree is a tree whose DNA has been modified using genetic engineering techniques. In most cases the aim is to introduce a novel trait to the plant which does not occur naturally within the species. Examples include resistance to certain pests, diseases, environmental conditions, and herbicide tolerance, or the alteration of lignin levels in order to reduce pulping costs.

Scott Nichols is an American inventor and marketer who is often considered to be a leader in the effort to make fish farming more sustainable. Nichols was part of the process and promotion of using a yeast rich in essential omega-3s (EPA) as an alternative food source for farmed salmon. He is the recipient of the 2012 SeaWeb Innovation Award, the 2015 IntraFish Seafood International Marketer of the Year Award, a co-founder of Verlasso, and founder of Food's Future. He serves on the board of the Aquaculture Stewardship Council.

<span class="mw-page-title-main">Alison Van Eenennaam</span> American biologist

Alison L. Van Eenennaam is a Cooperative Extension Specialist in the Department of Animal Science at the University of California, Davis and runs the Animal Genomics and Biotechnology Laboratory. She has served on national committees such as the USDA National Advisory Committee on Biotechnology in the 21st Century (AC21) and was awarded the 2014 Borlaug CAST Communication Award. Van Eenennaam writes the Biobeef Blog.

Genetic engineering in North America is any genetic engineering activities in North America

References

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.